The hypodermic needles market is driven by various factors such as the increasing prevalence of chronic diseases, the rising demand for vaccines and injectable drugs, and the growth of the geriatric population. The market is also fueled by technological advancements in needle design and manufacturing, leading to the development of safer, more efficient, and user-friendly needles. However, factors such as the high cost of safety needles and the risk of needlestick injuries pose challenges to the growth of the market. Additionally, the growing demand for needle-free injection systems and the rising popularity of alternative drug delivery methods such as oral and transdermal routes may hinder market growth. Overall, the Hypodermic Needles Market is expected to continue to grow as the demand for injectable therapies continues to rise.
Major Players in the Hypodermic Needles Industry:
Albert David:
Albert David Ltd. was founded in 1946 and is headquartered in Kolkata, India. The company manufactures a wide range of medical devices, including hypodermic needles. It operates in over 30 countries worldwide, including the United States, the United Kingdom, and Germany. In February 2022, the company announced the launch of its new line of safety-engineered hypodermic needles, which are designed to reduce the risk of needlestick injuries.
Becton, Dickinson and Company (BD):
BD was founded in 1897 and is headquartered in Franklin Lakes, New Jersey. It is a global medical technology company that develops and manufactures a wide range of medical devices, including hypodermic needles. BD operates in over 190 countries worldwide, including the United States, China, and Japan. In January 2023, BD announced the launch of its new line of ultra-thin hypodermic needles, which are designed to reduce pain and discomfort for patients.
Covidien:
Covidien was founded in 1903 and is headquartered in Dublin, Ireland. It is a global healthcare products company that develops and manufactures a wide range of medical devices, including hypodermic needles. Covidien operates in over 150 countries worldwide, including the United States, China, and Brazil. In June 2021, Covidien announced that it had received regulatory approval for its new line of safety-engineered hypodermic needles.
Hindustan Syringes & Medical Devices Limited (HMD):
HMD was founded in 1957 and is headquartered in Manesar, India. It is a leading manufacturer of medical devices, including hypodermic needles. HMD operates in over 100 countries worldwide, including the United States, the United Kingdom, and Australia. In April 2022, HMD announced that it had received regulatory approval for its new line of retractable hypodermic needles, which are designed to reduce the risk of needlestick injuries.
Nipro Medical Corporation:
Nipro Medical Corporation was founded in 1954 and is headquartered in Osaka, Japan. It is a global medical technology company that develops and manufactures a wide range of medical devices, including hypodermic needles. Nipro operates in over 60 countries worldwide, including the United States, China, and Germany. In March 2023, Nipro announced the launch of its new line of silicone-coated hypodermic needles, which are designed to reduce the risk of tissue damage and improve patient comfort.
Novo Nordisk:
Novo Nordisk was founded in 1923 and is headquartered in Bagsvaerd, Denmark. It is a global healthcare company that specializes in diabetes care and develops and manufactures a wide range of medical devices, including hypodermic needles. Novo Nordisk operates in over 80 countries worldwide, including the United States, China, and India. In May 2022, Novo Nordisk announced the launch of its new line of ultra-short hypodermic needles, which are designed to improve injection comfort for people with diabetes.
